CAD 0.06
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.34 Million CAD | 105.3% |
2022 | 1.14 Million CAD | 248.38% |
2021 | 328.02 Thousand CAD | 3.95% |
2020 | 315.57 Thousand CAD | 75.27% |
2019 | 180.05 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 2.55 Million CAD | 8.69% |
2024 Q2 | 2.56 Million CAD | 0.48% |
2023 Q2 | 1.7 Million CAD | 31.44% |
2023 Q4 | 2.34 Million CAD | 18.28% |
2023 FY | 2.34 Million CAD | 105.3% |
2023 Q1 | 1.29 Million CAD | 13.65% |
2023 Q3 | 1.98 Million CAD | 16.19% |
2022 Q3 | 995.44 Thousand CAD | 68.47% |
2022 Q1 | 400.1 Thousand CAD | 21.97% |
2022 FY | 1.14 Million CAD | 248.38% |
2022 Q4 | 1.14 Million CAD | 14.8% |
2022 Q2 | 590.87 Thousand CAD | 47.68% |
2021 Q1 | 216.66 Thousand CAD | -31.34% |
2021 FY | 328.02 Thousand CAD | 3.95% |
2021 Q3 | 636.83 Thousand CAD | -7.08% |
2021 Q2 | 685.32 Thousand CAD | 216.31% |
2021 Q4 | 328.02 Thousand CAD | -48.49% |
2020 Q2 | 240.49 Thousand CAD | 18.73% |
2020 Q4 | 315.57 Thousand CAD | -2.83% |
2020 Q1 | 202.55 Thousand CAD | 12.5% |
2020 Q3 | 324.74 Thousand CAD | 35.04% |
2020 FY | 315.57 Thousand CAD | 75.27% |
2019 Q4 | 180.05 Thousand CAD | 0.0% |
2019 FY | 180.05 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | 2.71 Million CAD | 13.737% |
Asep Medical Holdings Inc | 3.05 Million CAD | 23.124% |
BetterLife Pharma Inc. | 8.02 Million CAD | 70.748% |
BioVaxys Technology Corp. | 3.48 Million CAD | 32.689% |
ChitogenX Inc. | 6.71 Million CAD | 65.046% |
Rapid Dose Therapeutics Corp. | 5.04 Million CAD | 53.478% |
Defence Therapeutics Inc. | 4.06 Million CAD | 42.241% |
Entheon Biomedical Corp. | 85.32 Thousand CAD | -2649.614% |
Gemina Laboratories Ltd. | 3.04 Million CAD | 22.862% |
Lexston Life Sciences Corp. | 39.86 Thousand CAD | -5784.612% |
Pharmala Biotech Holdings Inc. | 1.02 Million CAD | -127.997% |
Doseology Sciences Inc. | 82.49 Thousand CAD | -2744.077% |
MYND Life Sciences Inc. | 5.77 Million CAD | 59.372% |
Nova Mentis Life Science Corp. | 841.66 Thousand CAD | -178.75% |
PharmaTher Holdings Ltd. | 252.9 Thousand CAD | -827.689% |
PreveCeutical Medical Inc. | 5.95 Million CAD | 60.633% |
Telescope Innovations Corp. | 1.35 Million CAD | -73.656% |